The Moderna (MRNA) stock price rose today after the flu vaccine showed promising results in a phase three trial. Is Moderna no longer a one hit wonder that was associated with Covid-19? The healthcare company expects to release 15 new products over the next 5 years. George Tsilis weighs in on possible upcoming booster shots.
Fast Market
13 Sep 2023
SHARE
Trading 360
30 Jan 2024
Market On Close
10 Apr 2024
Morning Trade Live
14 Feb 2024
Market On Close
08 Feb 2024
Market On Close
30 Jan 2024
Next Gen Investing
16 Apr 2024